StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Anbio Biotechnology Class A Ordinary Shares
NasdaqGM:NNNN
Sector
Location
Market Cap
USD 1.59 B
Share Price
USD 36.20
Avg Daily Volume
73,606
Change (1 day)
15.14%
Change (1 year)
Change (YTD)
366.50%
Anbio Biotechnology Class A Ordinary Shares Free Cash Flow for the year ending December 31, 2024: USD 2.08 M
Anbio Biotechnology Class A Ordinary Shares Free Cash Flow is USD 2.08 M for the year ending December 31, 2024, a 131.57% change year over year. Free cash flow is the amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.
-
Anbio Biotechnology Class A Ordinary Shares Free Cash Flow for the year ending December 31, 2023 was USD 898.37 K, a -79.81% change year over year.
-
Anbio Biotechnology Class A Ordinary Shares Free Cash Flow for the year ending December 31, 2022 was USD 4.45 M.
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
MERCK Kommanditgesellschaft auf Aktien
USD 132.97
MRK.DE
+0.27
0.20%
Agilent Technologies, Inc.
USD 120.66
A
+0.21
0.17%
Qiagen N.V.
USD 48.64
QGEN
+0.43
0.89%
Aurobindo Pharma Limited
USD 13.42
AUROPHARMA.NS
-0.11
-0.80%
Repligen Corporation
USD 126.96
RGEN
+0.52
0.41%
Bruker Corporation
USD 42.46
BRKR
+0.56
1.34%
Yuhan Corporation
USD 79.45
000100.KS
+1.42
1.82%
Pharmaron Beijing Co., Ltd.
USD 2.12
3759.HK
-0.01
-0.33%
Bachem Holding AG
USD 73.95
BANB.SW
+1.05
1.44%
Siegfried Holding AG
USD 112.79
SFZN.SW
-0.48
-0.42%
Gan & Lee Pharmaceuticals.
USD 7.82
603087.SS
-0.07
-0.89%
Cohance Lifesciences Limited
USD 11.51
COHANCE.NS
+0.21
1.84%
Bloomage BioTechnology Corporation Limited
USD 7.09
688363.SS
-0.12
-1.71%
Syngene International Limited
USD 7.45
SYNGENE.NS
-0.01
-0.09%
Metsera, Inc.
USD 28.86
MTSR
+1.98
7.37%
Jafron Biomedical Co.,Ltd.
USD 2.98
300529.SZ
-0.02
-0.55%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.20
300009.SZ
-0.04
-3.14%
Beijing Hotgen Biotech Co., Ltd.
USD 20.52
688068.SS
-1.30
-5.96%
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
USD 2.01
002675.SZ
-0.03
-1.63%
Key Data
| Date | Free Cash Flow | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities |
|---|
Competitors
Chugai Pharmaceutical Co., Ltd.
USD 48.90
4519.T
-0.57
-1.16%
MERCK Kommanditgesellschaft auf Aktien
USD 132.97
MRK.DE
+0.27
0.20%
Agilent Technologies, Inc.
USD 120.66
A
+0.21
0.17%
Qiagen N.V.
USD 48.64
QGEN
+0.43
0.89%
Aurobindo Pharma Limited
USD 13.42
AUROPHARMA.NS
-0.11
-0.80%
Repligen Corporation
USD 126.96
RGEN
+0.52
0.41%
Bruker Corporation
USD 42.46
BRKR
+0.56
1.34%
Yuhan Corporation
USD 79.45
000100.KS
+1.42
1.82%
Pharmaron Beijing Co., Ltd.
USD 2.12
3759.HK
-0.01
-0.33%
Bachem Holding AG
USD 73.95
BANB.SW
+1.05
1.44%
Siegfried Holding AG
USD 112.79
SFZN.SW
-0.48
-0.42%
Gan & Lee Pharmaceuticals.
USD 7.82
603087.SS
-0.07
-0.89%
Cohance Lifesciences Limited
USD 11.51
COHANCE.NS
+0.21
1.84%
Bloomage BioTechnology Corporation Limited
USD 7.09
688363.SS
-0.12
-1.71%
Syngene International Limited
USD 7.45
SYNGENE.NS
-0.01
-0.09%
Metsera, Inc.
USD 28.86
MTSR
+1.98
7.37%
Jafron Biomedical Co.,Ltd.
USD 2.98
300529.SZ
-0.02
-0.55%
Anhui Anke Biotechnology (Group) Co., Ltd.
USD 1.20
300009.SZ
-0.04
-3.14%
Beijing Hotgen Biotech Co., Ltd.
USD 20.52
688068.SS
-1.30
-5.96%
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.
USD 2.01
002675.SZ
-0.03
-1.63%